Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

Objective: The safety profiles of oral fluoropyrimidines were compared with 5-fluorouracil (5-FU) using adverse event reports (AERs) submitted to the Adverse Event Reporting System, AERS, of the US Food and Drug Administration (FDA). Methods: After a revision of arbitrary drug names and the deletion...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadoyama, Kaori, Miki, Ikuya, Tamura, Takao, Brown, JB, Sakaeda, Toshiyuki, Okuno, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222088/
https://www.ncbi.nlm.nih.gov/pubmed/22211087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222088/
https://www.ncbi.nlm.nih.gov/pubmed/22211087

Ejemplares similares